BioCentury | Nov 23, 2009
Clinical News

2-iminobiotin regulatory update

...Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Neurophyxia's 2-iminobiotin...
...plans to start Phase I testing next month. Neurophyxia B.V. , Utrecht, the Netherlands Product: 2-iminobiotin...
Items per page:
1 - 1 of 1